Davis Capaccioli
Optometrist · Durango, CONPI 1356879944
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Heru, Inc. at 47.0% of the total. Reporting peaked in 2022 at $2,814 and has fallen 96.1% since, to $109 in 2025. Among optometrist clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $154.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heru, Inc.$2K
- Coopervision Inc.$2K
- Alcon$149
- Johnson & Johnson Vision Care, Inc.$61
- Aerie Pharmaceuticals, Inc.$25
What the payments were for
- Consulting fees$1,60047%
- Travel & lodging$95328%
- Food & beverage$85425%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heru, Inc. | 1 | $1,600 |
| Coopervision Inc. | 12 | $1,572 |
| Alcon | 4 | $149 |
| Johnson & Johnson Vision Care, Inc. | 4 | $61 |
| Aerie Pharmaceuticals, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Heru HMD$1,600
- MyDay Contact Lens$146
How this compares
$3,407 in reported general payments places this provider in the 90th percentile of 1,025 optometrist providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 16 | $10,366 |
| LumiganBimatoprost | 11 | $6,295 |
| CombiganBrimonidine Tartrate/Timolol | 18 | $3,718 |
| Cyclosporine | 14 | $2,704 |
| Latanoprost | 181 | $1,958 |
| Prednisolone Acetate | 22 | $655 |
| Timolol Maleate | 43 | $402 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 21 | $231 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Durango
- Cecelia KoettingAurora$458K
- Kaleb AbbottAurora$145K
- Joshua OlsonBoulder$80K
- Felicia PopowskiFt Carson$80K
- Lisa HamiltonLittleton$73K
- Kent GodfreyGreenwood Village$49K
- Jason OrtmanCastle Pines$45K
- Scott GundersonBroomfield$43K
- Scot MorrisConifer$33K
- Betty ZhangDenver$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.